Latest Pharma Deals Draw Counsel from Am Law Firms

, The Am Law Daily


AstraZeneca has agreed to buy the rights to respiratory drugs owned by Almirall for $2.1 billion, with Covington & Burling and British firm CMS Cameron McKenna. Meanwhile, Kirkland & Ellis and Sidley Austin are leading the way on Pfizer's acquisition of Baxter International's vaccine portfolio.

This premium content is reserved for American Lawyer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202665323019

Thank you!

This article's comments will be reviewed.